GleamWall
中文EN

LLY ELI LILLY & Co

Pharmaceutical Preparations · NYSE · SEC CIK 59478 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY45.5%
TTM net income YoY49.8%
TTM EPS YoY50.7%
Revenue 3-yr CAGR39.2%
Net income 3-yr CAGR76.8%

Margins

Gross margin83.6%
Operating margin—
Net margin31.9%
FCF margin—
EBITDA margin—

Returns

ROE86.1%
ROA21.0%
ROIC (approx.)—
Asset turnover0.66x

Leverage & solvency

Liabilities / assets72.8%
Debt / equity1.23x
Current ratio1.39x
Interest coverage—

Cash quality & payout

Operating cash flow / net income1.11x
Accruals ratio-2.3%
Payout ratio21.7%
Capex / revenue—

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31
Income statement
Revenue$65.18B$45.04B
Cost of revenue$11.05B$8.42B
Gross profit$54.13B$36.62B
R&D expense$13.34B$10.99B
SG&A expense$11.09B$8.59B
Interest expense$895.00M$781.00M
Pretax income$25.73B$12.68B
Income tax$5.09B$2.09B
Net income$20.64B$10.59B
EPS (basic)23.0011.76
EPS (diluted)22.9511.71
Dividends declared per share6.235.40
Weighted avg. shares (diluted)899.30M904.10M
Balance sheet
Cash & equivalents$7.27B$3.27B
Short-term investments—$154.80M
Receivables$17.76B$11.01B
Inventory$13.74B$7.59B
Current assets$55.63B$32.74B
PP&E, net$24.68B$17.10B
Goodwill$5.90B$5.77B
Intangibles$6.52B$6.17B
Total assets$112.48B$78.72B
Current liabilities$35.23B$28.38B
Short-term debt$1.64B$5.12B
Long-term debt$40.87B$28.53B
Total debt$42.50B$33.64B
Total liabilities$85.94B$64.44B
Shareholders' equity$26.54B$14.27B
Net debt$35.23B$30.38B
Cash flow statement
Operating cash flow$16.81B$8.82B
Investing cash flow-$10.97B-$9.30B
Financing cash flow-$2.21B$1.23B
Depreciation & amortization$2.00B$1.77B
Stock-based compensation$626.00M$646.00M
Dividends paid$5.38B$4.68B
Share buybacks$4.11B$2.50B

Free plan shows the latest 2 periods; Pro shows all 19 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.